Discovery of Indazole Derivatives as a Novel Class of Bacterial Gyrase B Inhibitors

ACS Medicinal Chemistry Letters
2015.0

Abstract

Antibacterials with a novel mechanism of action offer a great opportunity to combat widespread antimicrobial resistance. Bacterial DNA Gyrase is a clinically validated target. Through physiochemical property optimization of a pyrazolopyridone hit, a novel class of GyrB inhibitors were discovered. Guided by structure-based drug design, indazole derivatives with excellent enzymatic and antibacterial activity as well as great animal efficacy were discovered.

Knowledge Graph

Similar Paper

Discovery of Indazole Derivatives as a Novel Class of Bacterial Gyrase B Inhibitors
ACS Medicinal Chemistry Letters 2015.0
Discovery of Pyrazolopyridones as a Novel Class of Gyrase B Inhibitors Using Structure Guided Design
ACS Medicinal Chemistry Letters 2016.0
Design, synthesis and structure–activity relationship studies of novel indazole analogues as DNA gyrase inhibitors with Gram-positive antibacterial activity
Bioorganic & Medicinal Chemistry Letters 2004.0
Synthesis and Antibacterial Activity of a Novel Series of Potent DNA Gyrase Inhibitors. Pyrazole Derivatives
Journal of Medicinal Chemistry 2004.0
Structure-guided design and development of novel benzimidazole class of compounds targeting DNA gyraseB enzyme of Staphylococcus aureus
Bioorganic & Medicinal Chemistry 2014.0
Structure-Based Discovery of Substituted 4,5′-Bithiazoles as Novel DNA Gyrase Inhibitors
Journal of Medicinal Chemistry 2012.0
New N-phenyl-4,5-dibromopyrrolamides as DNA gyrase B inhibitors
MedChemComm 2019.0
Novel Dual-Targeting Benzimidazole Urea Inhibitors of DNA Gyrase and Topoisomerase IV Possessing Potent Antibacterial Activity: Intelligent Design and Evolution through the Judicious Use of Structure-Guided Design and Stucture−Activity Relationships
Journal of Medicinal Chemistry 2008.0
Discovery of a novel azaindole class of antibacterial agents targeting the ATPase domains of DNA gyrase and Topoisomerase IV
Bioorganic & Medicinal Chemistry Letters 2012.0
New N -phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity
European Journal of Medicinal Chemistry 2018.0